1)Strickland RG, Mackay IR. A reappraisal of the nature and significance of chronic atrophic gastritis. Am J Dig Dis 18:426-440, 1973
2)Lee GR, Brithell TC, Foerster J. Megaloblstic and non-megaloblastic macrocytic anemias. Wintrobe's clinical hematology, 9th ed, Philaderphia and Febriger. pp 562-578, 1993
3)浅野茂隆,池田康夫,内山卓.三輪血液学,文光堂,東京,p 976, 2006
4)寺尾秀一,當銘正友,久禮泉,他.D群のほとんどは,「高度の萎縮とI.M.のためにH. pyloriが駆逐された」群ではない.日ヘリコバクター会誌 14:5-14, 2013
5)Yagi K, Nakamura A, Atsuo S, et al. Features of the atrophic corpus mucosa in three cases of autoimmune gastritis revealed by magnifying endoscopy. Case Rep Med 2012:368160, 2012
6)Stockbrugger RW, Menon GG, Beilby JOW, et al. Gastroscopic screening in 80 patients with pernicious anemia. Gut 24:1141-1147, 1983
7)春間賢,隅井浩治,今西幸市,他.悪性貧血の合併胃病変とその背景胃粘膜の検討.日内会誌 9:1393-1398, 1988
8)岸遂忠,杉山敏郎.胃癌の基礎─胃癌の病理:A型胃炎.消外 31:567-570, 2008
9)永原靖浩,田中彰一,小坂恒徳,他.A型胃炎の臨床的検討−胃腫瘍性病変,悪性貧血,H. pylori感染との関連について.医療 55:538-542, 2001
10)Haruma K, Komoto K, Kawaguchi H, et al. Pernicious anemia and Helicobacter pylori infection in Japan:evaluation in a country with a high prevalence of infection.Am J Gastroenterol 90:1107-1110, 1995
-adenosine triphosphatase in human gastric autoimmunity. J Exp Med 198:1147-1156, 2003
12)Lahner E, Norman GL, Severi C, et al. Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency. Am J Gastroenterol 204:2071-2079, 2009
13)Tozzoli R, Kodermaz G, Perosa AR, et al. Autoantibodies to parietal cells as predictors of atrophic body gastritis:a five-year prospective study in patients with autoimmune thyroid diseases. Autoimmun Rev 10:30-33, 2010
14)Antico A, Tampoia M, Villata D, et al. Clinical usefulness of the serological gastric biopsy for the diagnosis of chronic autoimmune gastritis. Clin Dev Immunol 2012:520970, 2012
15)池田知純,瀬上一誠,原雅文,他.胃カルチノイドを合併し“pseudopolyposis”様所見を呈したA型胃炎の1例.Gastroenterol Endosc 24:1927-1935, 1982
16)Neumann WL, Cross E, Rugge M, et al. Autoimmune atrophic gastritis─pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol 10:529-541, 2013
17)Toh BH. Diagnosis and classification of autoimmune gastritis. Autoimmun Rev 13:459-462, 2014
18)Gilligan CJ, Lawton GP, Tang LH, et al. Gastric carcinoid tumors:the biology and therapy of an enigmatic and controversial lesion. Am J Gastroenterol 90:338-352, 1995
19)Ruszniewski P, Delle Fave G, Cadiot G. Well-differentiated gastric tumors/carcinomas. Neuroendocrinology 84:158-164, 2006
20)Kuke MH, Benson AB, Bergsland E, et al; National Comprehensive Cancer Networks. Neuroendocrine Tumors. J Natl Compr Canc Netw 10:724-764, 2012
21)Sato Y, Imamura H, Kaizaki Y, et al. Management and clinical outcomes of type I gastric carcinoid patients:retrospective, multicenter study in Japan. Dig Endosc 26:377-384, 2014